Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001859061-22-000001
Filing Date
2022-07-25
Accepted
2022-07-25 19:16:25
Documents
1
Period of Report
2022-07-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3281
  Complete submission text file 0001859061-22-000001.txt   4839
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Issuer) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 544 KING STREET CHAPPAQUA NY 10514
Business Address 544 KING STREET CHAPPAQUA NY 10514 (914) 841-8818
A2A Pharmaceuticals, Inc. (Reporting) CIK: 0001859061 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40335 | Film No.: 221104605